Extra Strength Pretat
Product Images NDC 69804-018
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Extra Strength Pretat (NDC 69804-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ridge Properties, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Inactive Ingredients (Inactive Ingredients Section)
Indications And Usage (Indications And Usage)
Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)
Active Ingredients (Otc Active Ingredient)
This is a description for a product or medication that contains Lidocaine Hydrochloride (HCL) as its active ingredient with a concentration of 4%. Lidocaine is a local anesthetic that can be used for numbing the skin or mucous membranes to alleviate pain or discomfort caused by medical procedures or skin conditions.*
Principal Display Panel (Principal Display Panel)
This is a FDA registered drug with NDC# 69804-018-12. The drug contains Lidocaine HCL 4% and other inactive ingredients. This drug shouldn't be used if a person has any known allergy. It is only for professional use and not suitable for use around the eyes. In case of ingestion or any serious allergic reaction, medical attention is necessary. The product is manufactured, packed, and distributed by Pain Relief Naturally, and it is available in 4 ounces of gel. Prior to use, the skin should be tested for sensitivity. If the skin becomes irritated, use should be stopped and seek the help of a doctor. It is recommended not to use the drug on or near the eyes.*
Purpose (Purpose)
Warnings Section (Warnings Section)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.